Riggs Asset Managment Co. Inc. Editas Medicine, Inc. Transaction History

Riggs Asset Managment Co. Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$14.08 - $27.63 $2,816 - $5,526	-200 Closed	0 $0
Q1 2021 Apr 27, 2021	SELL	$39.71 - $90.58 $7,942 - $18,116	-200 Reduced 50.0%	200 $8,000
Q4 2020 Jan 29, 2021	BUY	$27.07 - $84.35 $10,828 - $33,740	400 New	400 $28,000
Q3 2020 Oct 13, 2020	SELL	$28.06 - $37.16 $11,224 - $14,863	-400 Closed	0 $0
Q3 2018 Oct 15, 2018	SELL	$27.65 - $38.39 $2,765 - $3,839	-100 Reduced 20.0%	400 $12,000
Q1 2018 Apr 17, 2018	BUY	$29.84 - $44.08 $2,984 - $4,408	100 Added 25.0%	500 $17,000
Q3 2017 Oct 30, 2017	BUY	$15.81 - $24.01 $6,324 - $9,604	400	400 $10,000

246

56.8M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $94.2M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Riggs Asset Managment Co. Inc., based on Form 13F filings with the SEC.

Stay updated on Riggs Asset Managment Co. Inc. with notifications on news.